A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse — Jean Yves Blay (2024) | RDL Network
Axel Le Cesne, Sylvie Chabaud, O. Bouche, Nicolas Penel, Mehdi Brahmi, Maud Toulmonde, Emmanuelle Bompas, François Bertucci, L. Chaigneau, W. Lahlou, B. Landi, B. Verret, Clémence Hénon, Diane Pannier, Marc Pracht, Olivier Collard, Isabelle Laure Ray-Coquard, Séverine Metzger, David Pérol, Jean Yves Blay
Axel Le Cesne, Camille Schiffler, Olivier Bouché, Mehdi Brahmi, F. Duffaud, Maud Toulmonde, B. Landi, W. Lahlou, Diane Pannier, Emmanuelle Bompas, François Bertucci, L. Chaigneau, Olivier Collard, Marc Pracht, Antoine Adenis, Isabelle Ray‐Coquard, Séverine Metzger, Sylvie Chabaud, David Pérol, Jean Yves Blay
Discussion(0)
No comments yet. Be the first to comment.